Please login to the form below

Not currently logged in
Email:
Password:

tardive dyskinesia

This page shows the latest tardive dyskinesia news and features for those working in and with pharma, biotech and healthcare.

FDA clears Teva's tardive dyskinesia drug Austedo

FDA clears Teva's tardive dyskinesia drug Austedo

FDA clears Teva's tardive dyskinesia drug Austedo. The twice-daily drug will compete with Neurocrine Bioscience’s Ingrezza. ... April. Tardive dyskinesia, a neurological disorder characterised by repetitive involuntary movements such as grimacing,

Latest news

More from news
Approximately 7 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics